[Our] basic thinking on AOD9604 is that the drug failed because it was made orally available, which likely reduced bioavailability and also potentially resulted in protein denaturisation in the gastrointestinal tract, which would have reduced the drugs activity
That distinction helps explain why people often describe BPC-157 as more targeted in online discussion and TB-500 as more systemic. Those are community shorthand descriptions, not formal clinical categories, but they reflect how the literature is commonly interpreted
J Clin Invest 123(1):92100
Alzheimers Dement 2016;12:719-32
IV Glutathione Therapy IV Glutathione therapy delivers this powerful antioxidant directly into the bloodstream, bypassing the digestive system for maximum absorption and effectiveness
Cellular support capabilities of copper peptides: A scientific perspective From a scientific standpoint, copper peptides are recognized for their role in various cellular activities